NASDAQ: BBTX
Bambusa Therapeutics Inc Stock Ownership - Who owns Bambusa Therapeutics?

Insider buying vs selling

Have Bambusa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Helmut Wolfgang JeggleDirector2026-11-02375,000$16.00
$6.00MBuy
Investment Gmbh Salvia10% Owner2026-11-02375,000$16.00
$6.00MBuy

1 of 1

BBTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBTX insiders and whales buy or sell their stock.

BBTX Shareholders

What type of owners hold Bambusa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Investment Gmbh Salvia18.62%9,264,301$138.87MInsider
Helmut Wolfgang Jeggle18.62%9,264,301$138.87MInsider
Shanshan Xu15.20%7,562,518$113.36MInsider

1 of 1

BBTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AARD0.04%46.39%Net SellingNet Selling
ABVC0.00%78.89%
ABVX0.07%0.00%
ACET0.04%99.96%Net Buying
TRXB0.00%37.74%Net BuyingNet Buying

Bambusa Therapeutics Stock Ownership FAQ

Who owns Bambusa Therapeutics?

Bambusa Therapeutics (NASDAQ: BBTX) is owned by 0.00% institutional shareholders, 52.43% Bambusa Therapeutics insiders, and 47.57% retail investors. Investment Gmbh Salvia is the largest individual Bambusa Therapeutics shareholder, owning 9.26M shares representing 18.62% of the company. Investment Gmbh Salvia's Bambusa Therapeutics shares are currently valued at $148.23M.

If you're new to stock investing, here's how to buy Bambusa Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.